Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Q4 2024

SeaStar Medical Holding (ICU) Q4 2024 earnings results (fourth quarter 2024)

10-K filed Mar 27, 2025

SeaStar Medical Holding (ICU) reported revenue of $67K for the fourth quarter 2024 (Q4 2024) and -1% from the quarter before.

Revenue$67K
Year over year—
Quarter over quarter-1%
Operating margin—
Net earnings−$4.4M

SeaStar Medical Holding, Q4 2024: revenue $67K, net loss $4.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.

Q4 2024AmountQ/QY/Y
Revenue$67K-1%—
Operating profit−$4.8M——
Net earnings−$4.4M——
Operating cash flow−$4.7M——

What changed

Revenue was $67K in Q4 2024, down 1% from the previous quarter.

Gross margin was 100.0%. Operating costs exceeded revenue by $4.8M, an operating margin of -7114.9%. The quarter ended with a net loss of $4.4M, narrower than the previous quarter's $4.5M loss.

Operating cash flow was −$4.7M. Non-cash charges added back $212K of share-based compensation. Working capital and other items used $486K.

Questions

What was SeaStar Medical Holding's revenue in the fourth quarter 2024?

SeaStar Medical Holding (ICU) reported revenue of $67K for the fourth quarter 2024 (Q4 2024) and -1% from the quarter before.

Open the interactive Sankey →

Source: SeaStar Medical Holding 10-K on SEC EDGAR.